Page last updated: 2024-09-03

leukotriene b5 and 5-hydroxy-6,8,11,14,17-eicosapentaenoic acid

leukotriene b5 has been researched along with 5-hydroxy-6,8,11,14,17-eicosapentaenoic acid in 1 studies

Compound Research Comparison

Studies
(leukotriene b5)
Trials
(leukotriene b5)
Recent Studies (post-2010)
(leukotriene b5)
Studies
(5-hydroxy-6,8,11,14,17-eicosapentaenoic acid)
Trials
(5-hydroxy-6,8,11,14,17-eicosapentaenoic acid)
Recent Studies (post-2010) (5-hydroxy-6,8,11,14,17-eicosapentaenoic acid)
5711814212

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aardestrup, I; Gammelmark, A; Madsen, T; Nielsen, MS; Obel, T; Schmidt, EB1

Trials

1 trial(s) available for leukotriene b5 and 5-hydroxy-6,8,11,14,17-eicosapentaenoic acid

ArticleYear
The effect of low-dose marine n-3 fatty acids on the biosynthesis of pro-inflammatory 5-lipoxygenase pathway metabolites in overweight subjects: a randomized controlled trial.
    Prostaglandins, leukotrienes, and essential fatty acids, 2012, Volume: 87, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cardiotonic Agents; Cell Membrane; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Male; Middle Aged; Multivariate Analysis; Neutrophils; Obesity, Abdominal; Overweight; Treatment Outcome

2012